Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNLI | RARE | CRSP | ||
| Company | Denali Therapeutics Inc | Ultragenyx Pharmaceu | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 29.63 | 48.41 | 49.85 | ||
| High | 29.80 | 48.60 | 50.10 | ||
| Low | 28.29 | 47.59 | 46.84 | ||
| Last | 28.45 | 47.64 | 46.85 | ||
| Change | -1.18 | -1.07 | -2.94 | ||
| % Change | -3.98% | -2.20% | -5.90% | ||
| Volume | 831,200 | 586,300 | 1,958,000 | ||
| 20-Day Average Volume | 758,500 | 874,630 | 1,632,845 | ||
| Previous Close | 29.63 | 48.71 | 49.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.95 | 51.90 | 49.40 | ||
| 20-Day Raw Stochastic | 37.28% | 0.53% | 10.35% | ||
| 20-Day Relative Strength | 51.99% | 34.14% | 45.81% | ||
| Weighted Alpha | +48.12 | +12.78 | -32.33 | ||
| Today's Opinion | 88% Buy | 8% Sell | 80% Sell | ||
| Previous Opinion | 88% Buy | 24% Buy | 40% Sell | ||
| Last Month's Opinion | 72% Buy | 96% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.89% since 11/07/24 | -5.53% since 11/07/24 | -9.70% since 11/07/24 | ||
| Low | 28.29 on 11/14/24 | 47.59 on 11/14/24 | 46.84 on 11/14/24 | ||
| High | 33.33 on 11/11/24 | 53.04 on 11/11/24 | 59.07 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | +6.04% since 10/14/24 | -15.22% since 10/14/24 | -2.04% since 10/14/24 | ||
| Low | 25.55 on 10/31/24 | 47.59 on 11/14/24 | 45.44 on 10/23/24 | ||
| High | 33.33 on 11/11/24 | 57.99 on 10/16/24 | 59.07 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +26.56% since 08/14/24 | -7.96% since 08/14/24 | +0.95% since 08/14/24 | ||
| Low | 22.82 on 08/15/24 | 47.59 on 11/14/24 | 43.42 on 09/06/24 | ||
| High | 33.33 on 11/11/24 | 60.37 on 09/16/24 | 59.07 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +44.05% since 05/14/24 | +16.28% since 05/14/24 | -15.90% since 05/14/24 | ||
| Low | 17.93 on 05/29/24 | 37.02 on 06/18/24 | 43.42 on 09/06/24 | ||
| High | 33.33 on 11/11/24 | 60.37 on 09/16/24 | 67.88 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,264,409 | 4,498,076 | 4,249,726 | ||
| Shares Outstanding, K | 143,922 | 92,344 | 85,353 | ||
| Annual Sales | 330,530,000 | 434,250,000 | 371,210,000 | ||
| Annual Net Income | -145,220,000 | -606,640,000 | -153,610,000 | ||
| Last Quarter Sales | 0 | 139,490,000 | 600,000 | ||
| Last Quarter Net Income | -107,190,000 | -133,520,000 | -85,940,000 | ||
| 60-Month Beta | 1.40 | 0.58 | 1.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/06/24 | -1.40 on 11/05/24 | -1.01 on 11/05/24 | ||
| Latest Earnings Date | 11/05/24 | 11/05/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||